Literature DB >> 21544929

Quantitative comparison of randomization designs in sequential clinical trials based on treatment balance and allocation randomness.

Wenle Zhao1, Yanqiu Weng, Qi Wu, Yuko Palesch.   

Abstract

To evaluate the performance of randomization designs under various parameter settings and trial sample sizes, and identify optimal designs with respect to both treatment imbalance and allocation randomness, we evaluate 260 design scenarios from 14 randomization designs under 15 sample sizes range from 10 to 300, using three measures for imbalance and three measures for randomness. The maximum absolute imbalance and the correct guess (CG) probability are selected to assess the trade-off performance of each randomization design. As measured by the maximum absolute imbalance and the CG probability, we found that performances of the 14 randomization designs are located in a closed region with the upper boundary (worst case) given by Efron's biased coin design (BCD) and the lower boundary (best case) from the Soares and Wu's big stick design (BSD). Designs close to the lower boundary provide a smaller imbalance and a higher randomness than designs close to the upper boundary. Our research suggested that optimization of randomization design is possible based on quantified evaluation of imbalance and randomness. Based on the maximum imbalance and CG probability, the BSD, Chen's biased coin design with imbalance tolerance method, and Chen's Ehrenfest urn design perform better than popularly used permuted block design, EBCD, and Wei's urn design.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21544929      PMCID: PMC3399213          DOI: 10.1002/pst.493

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  14 in total

1.  The clinical trial.

Authors:  A B HILL
Journal:  Br Med Bull       Date:  1951       Impact factor: 4.291

2.  A relevant question for site balanced studies relates to the comparative predictability of minimization to the alternative of permuted blocks.

Authors:  Damian McEntegart
Journal:  Contemp Clin Trials       Date:  2010-07-30       Impact factor: 2.226

3.  Varying the block size does not conceal the allocation.

Authors:  Vance W Berger
Journal:  J Crit Care       Date:  2006-06       Impact factor: 3.425

4.  A new proposal for setting parameter values in restricted randomization methods.

Authors:  G Kundt
Journal:  Methods Inf Med       Date:  2007       Impact factor: 2.176

5.  Efficient generation of constrained block allocation sequences.

Authors:  Ibrahim Salama; Anastasia Ivanova; Bahjat Qaqish
Journal:  Stat Med       Date:  2008-04-30       Impact factor: 2.373

Review 6.  A review of methods for ensuring the comparability of comparison groups in randomized clinical trials.

Authors:  Vance W Berger
Journal:  Rev Recent Clin Trials       Date:  2006-01

7.  Maximum entropy constrained balance randomization for clinical trials.

Authors:  J H Klotz
Journal:  Biometrics       Date:  1978-06       Impact factor: 2.571

8.  Properties of the urn randomization in clinical trials.

Authors:  L J Wei; J M Lachin
Journal:  Control Clin Trials       Date:  1988-12

9.  Minimization: a new method of assigning patients to treatment and control groups.

Authors:  D R Taves
Journal:  Clin Pharmacol Ther       Date:  1974-05       Impact factor: 6.875

10.  Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial.

Authors:  S J Pocock; R Simon
Journal:  Biometrics       Date:  1975-03       Impact factor: 2.571

View more
  17 in total

1.  Minimal sufficient balance-a new strategy to balance baseline covariates and preserve randomness of treatment allocation.

Authors:  Wenle Zhao; Michael D Hill; Yuko Palesch
Journal:  Stat Methods Med Res       Date:  2012-01-26       Impact factor: 3.021

2.  The impact of covariate adjustment at randomization and analysis for binary outcomes: understanding differences between superiority and noninferiority trials.

Authors:  Katherine Nicholas; Sharon D Yeatts; Wenle Zhao; Jody Ciolino; Keith Borg; Valerie Durkalski
Journal:  Stat Med       Date:  2015-02-02       Impact factor: 2.373

3.  Reducing heavy drinking in HIV primary care: a randomized trial of brief intervention, with and without technological enhancement.

Authors:  Deborah S Hasin; Efrat Aharonovich; Ann O'Leary; Eliana Greenstein; Martina Pavlicova; Srikesh Arunajadai; Rachel Waxman; Milton Wainberg; John Helzer; Barbara Johnston
Journal:  Addiction       Date:  2013-04-17       Impact factor: 6.526

4.  The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak.

Authors:  Mohamed Samai; Jane F Seward; Susan T Goldstein; Barbara E Mahon; Durodami Radcliffe Lisk; Marc-Alain Widdowson; Mohamed I Jalloh; Stephanie J Schrag; Ayesha Idriss; Rosalind J Carter; Peter Dawson; S A S Kargbo; Bailah Leigh; Mohamed Bawoh; Jennifer Legardy-Williams; Gibrilla Deen; Wendy Carr; Amy Callis; Robert Lindblad; James B W Russell; Carey R Petrie; Augustin E Fombah; Brima Kargbo; Wendi McDonald; Olamide D Jarrett; Robert E Walker; Paul Gargiullo; Donald Bash-Taqi; Laura Gibson; Abu Bakarr Fofanah; Anne Schuchat
Journal:  J Infect Dis       Date:  2018-05-18       Impact factor: 5.226

5.  Comparison of statistical and operational properties of subject randomization procedures for large multicenter clinical trial treating medical emergencies.

Authors:  Wenle Zhao; Yunming Mu; Darren Tayama; Sharon D Yeatts
Journal:  Contemp Clin Trials       Date:  2015-01-29       Impact factor: 2.226

6.  Randomization in clinical trials: stratification or minimization? The HERMES free simulation software.

Authors:  Hélène Fron Chabouis; Francis Chabouis; Florence Gillaizeau; Pierre Durieux; Gilles Chatellier; N Dorin Ruse; Jean-Pierre Attal
Journal:  Clin Oral Investig       Date:  2013-03-01       Impact factor: 3.573

7.  Managing competing demands in the implementation of response-adaptive randomization in a large multicenter phase III acute stroke trial.

Authors:  Wenle Zhao; Valerie Durkalski
Journal:  Stat Med       Date:  2014-05-22       Impact factor: 2.373

8.  HealthCall delivered via smartphone to reduce co-occurring drug and alcohol use in HIV-infected adults: A randomized pilot trial.

Authors:  Efrat Aharonovich; Malka Stohl; Daniela Cannizzaro; Deborah Hasin
Journal:  J Subst Abuse Treat       Date:  2017-09-29

9.  A better alternative to stratified permuted block design for subject randomization in clinical trials.

Authors:  Wenle Zhao
Journal:  Stat Med       Date:  2014-07-14       Impact factor: 2.373

10.  Reducing non-injection drug use in HIV primary care: A randomized trial of brief motivational interviewing, with and without HealthCall, a technology-based enhancement.

Authors:  Efrat Aharonovich; Aaron Sarvet; Malki Stohl; Don DesJarlais; Susan Tross; Teresa Hurst; Antonio Urbina; Deborah Hasin
Journal:  J Subst Abuse Treat       Date:  2016-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.